Injectable alpha-2 adrenergic antagonist which reverses sedative and analgesic effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs. Provides predictable, rapid reversal of sedation in 5 to 10 minutes. Smooth, controlled recovery with minimal risk for relapse into sedation.

MSDS: 

AntisedanMSDS.pdf